No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
CTLA-4 Antigen / antagonists & inhibitors*
-
Graft Rejection / etiology*
-
Graft Survival
-
Humans
-
Kidney Failure, Chronic / complications
-
Kidney Failure, Chronic / surgery*
-
Kidney Transplantation / adverse effects*
-
Male
-
Melanoma / drug therapy*
-
Melanoma / etiology
-
Melanoma / secondary
-
Postoperative Complications*
-
Prognosis
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Risk Factors
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / etiology
-
Skin Neoplasms / pathology
-
Transplant Recipients
Substances
-
Antineoplastic Agents
-
CTLA-4 Antigen
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor